This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Core Laboratories (CLB) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 55.56% and 0.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oilfield Services Q2 Preview: It's Not All Gloom and Doom
by Nilanjan Choudhury
The oil service companies will be in the limelight early next week as second-quarter earnings reports for the group start rolling in.
Halliburton (HAL) With TechnipFMC Launches Odassea Technology
by Zacks Equity Research
In the newly-unveiled Odassea technology, Halliburton (HAL) will be responsible for the fiber optic sensing technology, completions and analysis for reservoir diagnostics.
8 Factors That Make Diamondback (FANG) an Attractive Bet Now
by Zacks Equity Research
The acquisitions of Energen and Ajax Resources convert Diamondback (FANG) into one of the leading Permian Basin oil producers.
Core Labs Adjusts Credit Facility, Grows Annual Cost Savings
by Zacks Equity Research
Core Laboratories (CLB) enters the second phase of cost management wherein total annualized cost savings are now projected at $61 million and quarterly savings, expected to cross $15 million.
HollyFrontier's Cheyenne Refinery to Adapt to Diesel Unit
by Zacks Equity Research
HollyFrontier (HFC) projects its capex view in the $525-$625 million band, of which its refining unit is expected to spend between $202 million and $221 million.
Halliburton Cuts Dividend in a Drastic Step to Preserve Cash
by Zacks.com
Halliburton's (HAL) board members consent to a 20% voluntary cut in their annual salaries.
Why Is Core Laboratories (CLB) Up 31.8% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Oil & Gas Stock Roundup: BP, Kinder Morgan & Baker Hughes Report Q1 Earnings
by Nilanjan Choudhury
BP plc (BP) missed earnings estimates, Kinder Morgan (KMI) reported in line, while Baker Hughes (BKR) came out with better-than-expected bottom-line number.
Core Labs' (CLB) Q1 Earnings Miss, Sales Beat Estimates
by Zacks Equity Research
In a bid to sustain a strong balance sheet and lower the debt load, Core Labs (CLB) trims its quarterly cash dividend to a penny per share from the prior dividend of 25 cents.
Core Laboratories (CLB) Lags Q1 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International
A Pre-Earnings Analysis of the Oilfield Services Sector
by Nilanjan Choudhury
The oilfield service companies' Q1 earnings are likely to bear scars of activity slump on account of coronavirus-induced crude price plunge.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Pick Core Laboratories (CLB) Stock?
by Zacks Equity Research
Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates
by Zacks Equity Research
Core Laboratories (CLB) Q4 results benefit from cost-control initiatives and operational efficiencies.
Core Laboratories (CLB) Matches Q4 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for January 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Oil & Gas Stock Roundup: ExxonMobil's Q4 Update, Core Labs' Dividend Cut & More
by Nilanjan Choudhury
Supermajor ExxonMobil (XOM) issued an update on its upcoming fourth-quarter earnings. Meanwhile, Core Labs (CLB) slashed its dividend by 55% and lowered fourth-quarter guidance.
Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance
by Zacks Equity Research
Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.
Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.